1. Home
  2. CISO vs AKTX Comparison

CISO vs AKTX Comparison

Compare CISO & AKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CISO
  • AKTX
  • Stock Information
  • Founded
  • CISO 2015
  • AKTX N/A
  • Country
  • CISO United States
  • AKTX United States
  • Employees
  • CISO N/A
  • AKTX N/A
  • Industry
  • CISO Computer Software: Prepackaged Software
  • AKTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CISO Technology
  • AKTX Health Care
  • Exchange
  • CISO Nasdaq
  • AKTX Nasdaq
  • Market Cap
  • CISO 32.7M
  • AKTX 32.8M
  • IPO Year
  • CISO N/A
  • AKTX N/A
  • Fundamental
  • Price
  • CISO $1.26
  • AKTX $1.08
  • Analyst Decision
  • CISO
  • AKTX
  • Analyst Count
  • CISO 0
  • AKTX 0
  • Target Price
  • CISO N/A
  • AKTX N/A
  • AVG Volume (30 Days)
  • CISO 98.7K
  • AKTX 27.7K
  • Earning Date
  • CISO 11-18-2024
  • AKTX 02-24-2025
  • Dividend Yield
  • CISO N/A
  • AKTX N/A
  • EPS Growth
  • CISO N/A
  • AKTX N/A
  • EPS
  • CISO N/A
  • AKTX N/A
  • Revenue
  • CISO $54,633,909.00
  • AKTX N/A
  • Revenue This Year
  • CISO $78.76
  • AKTX N/A
  • Revenue Next Year
  • CISO N/A
  • AKTX N/A
  • P/E Ratio
  • CISO N/A
  • AKTX N/A
  • Revenue Growth
  • CISO 34.87
  • AKTX N/A
  • 52 Week Low
  • CISO $0.26
  • AKTX $0.90
  • 52 Week High
  • CISO $3.84
  • AKTX $4.40
  • Technical
  • Relative Strength Index (RSI)
  • CISO 54.18
  • AKTX 43.34
  • Support Level
  • CISO $0.96
  • AKTX $1.10
  • Resistance Level
  • CISO $1.03
  • AKTX $1.33
  • Average True Range (ATR)
  • CISO 0.09
  • AKTX 0.15
  • MACD
  • CISO 0.05
  • AKTX -0.01
  • Stochastic Oscillator
  • CISO 80.22
  • AKTX 5.97

About CISO CISO Global Inc.

CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.

About AKTX Akari Therapeutics plc ADS

Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).

Share on Social Networks: